37629005|t|The epsilon-Isozyme of Protein Kinase C (PKCepsilon) Is Impaired in ALS Motor Cortex and Its Pulse Activation by Bryostatin-1 Produces Long Term Survival in Degenerating SOD1-G93A Motor Neuron-like Cells.
37629005|a|Amyotrophic lateral sclerosis (ALS) is a rapidly progressive and ultimately fatal neurodegenerative disease, characterized by a progressive depletion of upper and lower motor neurons (MNs) in the brain and spinal cord. The aberrant regulation of several PKC-mediated signal transduction pathways in ALS has been characterized so far, describing either impaired expression or altered activity of single PKC isozymes (alpha, beta, zeta and delta). Here, we detailed the distribution and cellular localization of the epsilon-isozyme of protein kinase C (PKCepsilon) in human postmortem motor cortex specimens and reported a significant decrease in both PKCepsilon mRNA (PRKCE) and protein immunoreactivity in a subset of sporadic ALS patients. We furthermore investigated the steady-state levels of both pan and phosphorylated PKCepsilon in doxycycline-activated NSC-34 cell lines carrying the human wild-type (WT) or mutant G93A SOD1 and the biological long-term effect of its transient agonism by Bryostatin-1. The G93A-SOD1 cells showed a significant reduction of the phosphoPKCepsilon/panPKCepsilon ratio compared to the WT. Moreover, a brief pulse activation of PKCepsilon by Bryostatin-1 produced long-term survival in activated G93A-SOD1 degenerating cells in two different cell death paradigms (serum starvation and chemokines-induced toxicity). Altogether, the data support the implication of PKCepsilon in ALS pathophysiology and suggests its pharmacological modulation as a potential neuroprotective strategy, at least in a subgroup of sporadic ALS patients.
37629005	41	51	PKCepsilon	Gene	5581
37629005	68	71	ALS	Disease	MESH:D000690
37629005	170	174	SOD1	Gene	6647
37629005	175	179	G93A	ProteinMutation	tmVar:p|SUB|G|93|A;HGVS:p.G93A;VariantGroup:0;CorrespondingGene:6647;RS#:121912438;CorrespondingSpecies:9606;CA#:257327
37629005	205	234	Amyotrophic lateral sclerosis	Disease	MESH:D000690
37629005	236	239	ALS	Disease	MESH:D000690
37629005	287	312	neurodegenerative disease	Disease	MESH:D019636
37629005	459	462	PKC	Gene	112476
37629005	504	507	ALS	Disease	MESH:D000690
37629005	756	766	PKCepsilon	Gene	5581
37629005	855	865	PKCepsilon	Gene	5581
37629005	872	877	PRKCE	Gene	5581
37629005	932	935	ALS	Disease	MESH:D000690
37629005	1029	1039	PKCepsilon	Gene	5581
37629005	1043	1054	doxycycline	Chemical	MESH:D004318
37629005	1065	1071	NSC-34	CellLine	CVCL:D356
37629005	1127	1131	G93A	ProteinMutation	tmVar:p|SUB|G|93|A;HGVS:p.G93A;VariantGroup:0;CorrespondingGene:6647;RS#:121912438;CorrespondingSpecies:9606;CA#:257327
37629005	1132	1136	SOD1	Gene	6647
37629005	1201	1213	Bryostatin-1	Chemical	MESH:C046785
37629005	1219	1224	G93A-	CellLine	CVCL:B0K0
37629005	1224	1228	SOD1	Gene	6647
37629005	1369	1379	PKCepsilon	Gene	5581
37629005	1383	1395	Bryostatin-1	Chemical	MESH:C046785
37629005	1437	1442	G93A-	CellLine	CVCL:B0K0
37629005	1442	1446	SOD1	Gene	6647
37629005	1545	1553	toxicity	Disease	MESH:D064420
37629005	1604	1614	PKCepsilon	Gene	5581
37629005	1618	1621	ALS	Disease	MESH:D000690
37629005	1758	1761	ALS	Disease	MESH:D000690

